Following these promising results, they extended their pursuit to the more challenging type of tumor, GBM, and demonstrated that 89Zr-DFO-OX40 mAb PET specifically delineates stimulated lymphoid organs following the administration of a cancer vaccine applied in an orthotopic GBM model. Here, TNFRSF4 is linked to glioblastoma.